Surghive, a clinically led robotic surgery training company, has raised £320 thousand in seed funding led by SFC Capital. The Chadda Family and angel investors from the Lifted Ventures network also invested in the round. The investment will support Surghive as it develops manufacturer-independent training for robotic surgery.
Surghive is developing immersive training software for surgeons and surgical teams learning robotic surgery, in response to the rapid adoption of robotic surgery and the need for accessible, scalable training for surgeons and the wider operating theatre team. Its manufacturer-independent approach is designed to give healthcare professionals the chance to develop and practise skills without training being confined to a single robotic platform. The platform and its associated products remain in development. Surghive is the trading name of Robohive Ltd and is based in Teesside, North East England.
Surghive was founded by Rachael Coates, a robotic colorectal surgeon and chief executive, Christi Anderson, a finance and operations leader with more than two decades in financial services and professional services, including as a director at PwC, and Deena Harji, a consultant colorectal surgeon, academic and chief medical officer. Andy Wood, a technology business leader and former executive chairman of Cubic Motion, which Epic Games acquired in 2020, was appointed non-executive chairman in October.
Surghive will use the investment to continue developing its technology, strengthen its commercial proposition and progress plans to bring its immersive training platform to the surgical community. A national pilot is planned for November and December 2026, with an app launch in March 2027. The investment was announced on 21 October 2026 at Seven Kingdoms of Innovation and the Capital, a private event at the London Stock Exchange that brought together science and technology founders, investors and business leaders from across the UK.
Robotic surgery is advancing rapidly and training needs to keep pace. Our aim is to create a flexible and accessible way for surgeons and surgical teams to develop their skills, irrespective of the robotic system they are using. Securing investment from SFC Capital and the Chadda Family is an important endorsement of that ambition and gives us additional momentum as we develop the platform.
This investment enables us to accelerate that work and continue building a product designed around the real-world requirements of surgeons, surgical teams and healthcare organisations.
Effective training is fundamental to the safe and successful adoption of new surgical technologies. Surghive brings clinical experience and technology together with the aim of creating training that is practical, relevant and capable of evolving as robotic surgery itself evolves.
Surghive is addressing an important challenge at the intersection of healthcare, technology and education. As robotic surgery becomes increasingly established, there is a clear need for training solutions that can develop alongside the technology and be delivered at scale. We have been impressed by the combination of clinical knowledge, technical ambition and commercial thinking within the Surghive team and look forward to supporting the company as it develops its technology and takes the next steps towards commercialisation.
We were attracted to Surghive because it is solving a real problem and isn’t technology for technology’s sake. Robotic surgery is developing incredibly quickly, but the training has to develop with it. Giving surgeons the opportunity to practise and improve in an immersive environment has enormous potential. We also really liked the team and at this stage of a company’s journey, you are investing in people as much as you are investing in technology.
